EGFR and prostate carcinoma: In human prostate cancer several RTKs including the EGFR family (HER1, 2, and 3), PDGFR (alpha, beta), c-Ret and ephrin (EPH) are over-expressed compared to normal prostatic tissue [16-18], implicating pivotal roles in tumorigenesis.